Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis
Comment: This meta-analysis provides important, ‘Moderate’ certainty evidence that supports a clinical approach that’s simple to implement. The key takeaway is the non-inferiority of intermittent androgen deprivation (IAD) regarding overall survival. While the summary notes minimal difference in overall quality of life, the qualitative data suggesting improvements in physical and sexual functioning is clinically significant. […]
